PharmaCyte Biotech, Inc. Stock Analysis & AI Score
PharmaCyte Biotech, Inc. (PMCB) has an ST Score of 41.4 (C), driven by its Financial Strength (A+) and held back by its Growth (F). Analysts rate it Hold.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
PharmaCyte Biotech, Inc. (PMCB) has an ST Score of 41.4 (C), driven by its Financial Strength (A+) and held back by its Growth (F). Analysts rate it Hold.
- Strongest
- Financial StrengthA+
- Weakest
- GrowthF
All factor grades
- Financial StrengthA+
- ProfitabilityB
- ValuationB-
- MomentumD+
- GrowthF
- Piotroski2/9
Contact
PMCB stock: frequently asked questions
What is PMCB's ST Score?
PharmaCyte Biotech, Inc. (PMCB) has an ST Score of 41.4 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is PMCB a buy, hold, or sell?
Analysts rate PMCB a Hold. Our ST Score grades it C (41.4/100). The ST Score is a data-driven signal, not a recommendation.
What are PMCB's factor grades?
Valuation B-, Profitability B, Financial Strength A+, Momentum D+, Growth F.
What is PMCB's valuation grade?
PharmaCyte Biotech, Inc. (PMCB) earns a valuation grade of B-, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is PMCB's growth grade?
PharmaCyte Biotech, Inc. (PMCB) earns a growth grade of F, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is PMCB's profitability grade?
PharmaCyte Biotech, Inc. (PMCB) earns a profitability grade of B, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is PMCB's financial strength grade?
PharmaCyte Biotech, Inc. (PMCB) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is PMCB's Piotroski score?
PharmaCyte Biotech, Inc. (PMCB) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.